addmedica - Chairman's foreword

addmedica is dedicated to providing high medical value to physicians, patients, and managed care organisations, by developing, registering and marketing a wide range of medical products in several rare and debilitating diseases throughout Europe.

The company is proud to offer its current range of products in the fields of lung transplantation, wound healing and deep burn care. An orphan drug indicated in the sickle cell disease is also in final stage of marketing approval process.

addmedica is constantly looking for new opportunities and partnerships, to develop and commercialise products with high medical demand.

As a result of its know-how, its commitment and its positioning, addmedica is ready to become a leading European firm for the provision of medical products for rare diseases with the best quality of services.

François Anger
Chairman